What Is Retatrutide? Phase 3 Trials, the FDA Approval Process and Safety Warnings
What is retatrutide, the triple hormone agonist (GIP/GLP-1/glucagon) developed by Eli Lilly? NEJM Phase 2 results, the TRIUMPH Phase 3 program, where FDA approval stands and clear safety warnings.